Aneeve wins SBIR $750K Grant. See MIT Technology Review, Jan 2010.

The company uses carbon nanotube circuit printing technology and novel surface chemistry to create disposable POC hormone testing devices similar to blood glucose monitors. The initial targets are in post-menopausal hormone replacement therapy and In Vitro Fertilization (IVF) markets. The company is part of the California Nano-Science Institute (CNSI) Incubator located at UCLA.

FloVision^MD is a medical device manufacturer developing an imaging flow microscope platform. The company is currently focused on products for the hematology market. FloVision^MD’s proprietary technology utilizes an ultrafast camera and advanced image processing hardware to capture and identify digital images of every cell in a typical blood sample. This technology will reduce labor costs of hospitals and diagnostic labs by decreasing the number of samples which need to be reviewed under a microscope, i.e. manual reviews, and by reducing the time it takes to conduct a review.

Molecular Morse Code

Molecular Morse Code is developing devices which are capable of measuring gene expression levels of a single cell without using the traditional replication process (PCR). Atomic Force Microscopes (AFMs) actually “feel” for the mRNA strands attached to a medium, and based on overall length and known cut intervals, the devices can determine mRNA genes being expressed quantitatively.

Surro Immunology

Surro Immunology may hold the keys to an HIV/AIDS vaccine and therapeutics as well as therapeutics for autoimmune (e.g. Rheumatoid Arthritis, MS) and other diseases causing immune dysfunction. The company has been working on identifying a therapeutic affecting T Regulator Cells for over 15 years and has been issued several patents.